- Home
- BW vs NTHI Comparison
BW vs NTHI Comparison
Compare BW & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BW
- NTHI
- Stock Information
- Founded
- BW 1867
- NTHI 2008
- Country
- BW United States
- NTHI United States
- Employees
- BW N/A
- NTHI N/A
- Industry
- BW Building Products
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- BW Industrials
- NTHI Health Care
- Exchange
- BW Nasdaq
- NTHI Nasdaq
- Market Cap
- BW 95.7M
- NTHI 110.9M
- IPO Year
- BW N/A
- NTHI N/A
- Fundamental
- Price
- BW $1.04
- NTHI $4.40
- Analyst Decision
- BW Strong Buy
- NTHI
- Analyst Count
- BW 1
- NTHI 0
- Target Price
- BW $5.00
- NTHI N/A
- AVG Volume (30 Days)
- BW 816.2K
- NTHI 282.5K
- Earning Date
- BW 08-07-2025
- NTHI 01-01-0001
- Dividend Yield
- BW N/A
- NTHI N/A
- EPS Growth
- BW N/A
- NTHI N/A
- EPS
- BW N/A
- NTHI N/A
- Revenue
- BW $734,239,000.00
- NTHI $79,990.00
- Revenue This Year
- BW $5.81
- NTHI N/A
- Revenue Next Year
- BW $9.24
- NTHI N/A
- P/E Ratio
- BW N/A
- NTHI N/A
- Revenue Growth
- BW 12.90
- NTHI 13.52
- 52 Week Low
- BW $0.22
- NTHI $3.20
- 52 Week High
- BW $2.99
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- BW 55.15
- NTHI N/A
- Support Level
- BW $0.99
- NTHI N/A
- Resistance Level
- BW $1.10
- NTHI N/A
- Average True Range (ATR)
- BW 0.06
- NTHI 0.00
- MACD
- BW -0.01
- NTHI 0.00
- Stochastic Oscillator
- BW 70.59
- NTHI 0.00
About BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").